RACIAL DIFFERENCES IN OVEREXPRESSION OF EPIDERMAL GROWTH FACTOR TYPE II RECEPTOR (HER2/ NEU): A MAJOR PROGNOSTIC INDICATOR AND NOVEL THERAPEUTIC TARGET IN UTERINE SEROUS PAPILLARY CANCER
RACIAL DIFFERENCES IN OVEREXPRESSION OF EPIDERMAL GROWTH FACTOR TYPE II RECEPTOR (HER2/ NEU): A MAJOR PROGNOSTIC INDICATOR AND NOVEL THERAPEUTIC TARGET IN UTERINE SEROUS PAPILLARY CANCER